Paperonium

← Back to the plain-language case

Abstract states a 60-fold affinity difference; the paper's reported dissociation constants imply about 2-fold

eLife (2021) · doi:10.7554/eLife.48840 · PMC8257255

Summary

The abstract says that FasL binds DR5 with an affinity "approximately 60-fold lower than the affinity between TRAIL and DR5". The only affinity values in the paper are two surface plasmon resonance (SPR) dissociation constants in the Results: KD = 1.23 × 10−12 M for DR5–FasL and 6.01 × 10−13 M for DR5–TRAIL. Their ratio is 2.05, so the paper's own numbers support a roughly 2-fold difference, 29 times smaller than the abstract states. No simple slip in either number gives 60, and nothing in the deposited SPR source data gives 60 either. The abstract is where most readers learn how strong the newly proposed FasL–DR5 interaction is, so the stated magnitude matters. The direction of the comparison (FasL binds more weakly than TRAIL) is the same in both places.

What the paper reports

The PMC text flattens superscripts ("10-12"). Below they are written as superscripts, as in the eLife version of record and the Europe PMC JATS markup. The wording is otherwise verbatim.

Abstract:

Subsequent cellular and biochemical analyses revealed that DR5 interacted specifically with recombinant FasL–Fc protein, although the strength of this interaction was approximately 60-fold lower than the affinity between TRAIL and DR5.

Results, section "DR5 is a Fas-independent receptor for sFasL that promotes arthritis":

Furthermore, specific binding of DR5 to FasL was confirmed by surface plasmon resonance (KD: 1.23 × 10−12 M for DR5–FasL versus 6.01 × 10−13 M for DR5–TRAIL; Figure 1—figure supplement 4F,G)

Legend of Figure 1—figure supplement 4:

(F, G) Surface plasmon resonance assays for DR5–FasL (F) and DR5–TRAIL (G) interactions.

Materials and methods, "Surface Plasmon resonance":

To determine equilibrium affinity measurements, recombinant DR5 (R and D systems: 631-T2-100) was coupled with a CM5 sensor chip using 10 mM sodium acetate (pH 5.5), and recombinant FasL or TRAIL (R and D Systems: 126-FL-010) was passed over the chip at a flow rate of 30 μL/min for 120 s.

BIA evaluation software version 3.1 (GE Healthcare) was used for to analyze the data.

No other KD, affinity constant or fold-difference in affinity appears anywhere in the article text, figure legends or tables.

What the paper's own numbers show

Method. A lower affinity means a larger KD, so the fold by which FasL–DR5 affinity is lower than TRAIL–DR5 affinity is KD(FasL) / KD(TRAIL). I computed this ratio from the two printed values, allowed for rounding of their last digit, and worked out what either KD would have to be for the ratio to be 60. I then checked whether a single slip in a mantissa or exponent could turn the printed values into a 60-fold ratio. Finally I set the printed KDs against the analyte concentrations listed in the eLife source data for panels 4F and 4G. Every number below is printed by recompute.py.txt.

Quantity Location Reported Recomputed from the paper's own numbers
KD, DR5–FasL Results; Fig. 1—fig. suppl. 4F 1.23 × 10−12 M (input)
KD, DR5–TRAIL Results; Fig. 1—fig. suppl. 4G 6.01 × 10−13 M (input)
Fold lower affinity, FasL vs TRAIL Abstract approximately 60-fold 2.05 (1.23 × 10−12 / 6.01 × 10−13 = 2.0466; 2.037 to 2.057 allowing for rounding)
Abstract value ÷ implied value derived — 60 / 2.0466 = 29.3
KD(FasL) that a 60-fold ratio would need, if KD(TRAIL) is as printed derived — 3.61 × 10−11 M (29.3 × the printed value)
KD(TRAIL) that a 60-fold ratio would need, if KD(FasL) is as printed derived — 2.05 × 10−14 M (29.3 × below the printed value)
Ratios under single-digit or single-exponent slips derived — 0.205, 10, 20.5 or 205; none near 60
Analyte concentrations injected Figure 1 source data 1, panels 4F and 4G FasL 125, 250, 500, 1000 nM; TRAIL 15.625 to 250 nM lowest concentration ÷ printed KD: 1.0 × 105 (FasL), 2.6 × 104 (TRAIL)

The two printed constants share the same unit (M), so the ratio is dimensionless and does not depend on unit conventions. It also does not depend on whether one speaks of "affinity" as 1/KD: the TRAIL-to-FasL affinity ratio is still 2.05, and FasL's affinity is 0.489 times TRAIL's. To reach 60 one of the two constants would have to be about 29 times different from its printed value, and no change of one digit or one power of ten in either does that.

Figure

The abstract's 60-fold affinity difference set against the 2.05-fold ratio of the two dissociation constants printed in the Results

Figure 1. Top: the two passages that make the same comparison. Orange text marks values as printed in the paper; blue marks the ratio computed from them. Bottom: the same comparison on a log fold axis, with the thin line at 1 for equal affinity. The ratio of the printed KDs is 2.05 (blue circle). The abstract states approximately 60 (orange diamond). The two differ by a factor of 29. A log axis is used because the quantity is a ratio; it shows the distance between the two values at its true proportion.

The printed dissociation constants, the values a 60-fold difference would need, and the concentrations injected, on one concentration axis

Figure 2. Concentration on a log axis. Orange diamonds: the KDs printed in the Results. Blue open circles: the KD each interaction would need for the abstract's 60-fold figure to hold if the other KD is as printed (3.61 × 10−11 M for FasL; 2.05 × 10−14 M for TRAIL). Grey bars with tick marks: the analyte concentrations injected, taken from the eLife source data for Figure 1—figure supplement 4F and 4G. A 60-fold difference would need one constant to move by a factor of 29. The figure also shows that both printed KDs lie four to five orders of magnitude below the lowest concentration injected. This bears on how well the KDs are determined (see Explanations considered).

Why it matters

Explanations considered

Status

Suggested correction

The authors should say which measurement supports the abstract's fold-difference, then make the abstract and the Results agree. If the SPR constants in the Results are the intended basis, the abstract sentence could read:

Subsequent cellular and biochemical analyses revealed that DR5 interacted specifically with recombinant FasL–Fc protein, although the strength of this interaction was approximately 2-fold lower than the affinity between TRAIL and DR5.

If the 60-fold figure comes from another measurement or comparison (for example FasL–Fas, as in the wording suggested during review), that measurement and its value should be reported in the Results and the abstract's comparator corrected to match. Because the deposited sensorgrams show essentially no dissociation and the printed picomolar KDs lie 104 to 105 times below the lowest concentration injected, the authors may also wish to report ka, kd and their uncertainties, or the range of KD that the data can support. They may also wish to correct the injection time given in the Methods for TRAIL (100 s in the source data, 120 s in the text).